Home/Rani Therapeutics/Tiffany Barry
TB

Tiffany Barry

Chief Financial Officer

Rani Therapeutics

Rani Therapeutics Pipeline

DrugIndicationPhase
RT-102OsteoporosisPhase 1
RT-111Inflammatory Diseases (Ustekinumab Biosimilar)Phase 1